7 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Algorithm for Metformin ... Prescribing and Dosing ... in CKD Dose Initiation ... #Prescribing #Dosing ... #algorithm #diabetes
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... and sodium • Dosing ... binds magnesium • Dosing ... and calcium • Dosing ... #pharmacology #table
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... require phosphate binding ... since they are not able ... Purposes Only* #CKD ... Hyperphosphatemia #Dose #Dosing
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
oral suspension DOSING ... patients with CKD ... , HF, or diabetes ... effect is GI upset (constipation
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
the lgE, cross-linking ... blood types or during ... dermatitis, type I diabetes ... Hypersensitivity #Types #Classification ... Diagnosis #Reactions #Table
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
and laboratory findings ... Skin Disease Classification ... pancreatitis, protein-losing ... Valvular disorders • CAD